Skip to main content

Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria

Author(s): Mor, Danielle E; Sohrabi, Salman; Kaletsky, Rachel; Keyes, William; Tartici, Alp; et al

Download
To refer to this page use: http://arks.princeton.edu/ark:/88435/pr1td9n73q
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMor, Danielle E-
dc.contributor.authorSohrabi, Salman-
dc.contributor.authorKaletsky, Rachel-
dc.contributor.authorKeyes, William-
dc.contributor.authorTartici, Alp-
dc.contributor.authorKalia, Vrinda-
dc.contributor.authorMiller, Gary W-
dc.contributor.authorMurphy, Coleen T-
dc.date.accessioned2022-01-25T14:52:35Z-
dc.date.available2022-01-25T14:52:35Z-
dc.date.issued2020-10-06en_US
dc.identifier.citationMor, Danielle E, Sohrabi, Salman, Kaletsky, Rachel, Keyes, William, Tartici, Alp, Kalia, Vrinda, Miller, Gary W, Murphy, Coleen T. (2020). Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria.. Proceedings of the National Academy of Sciences of the United States of America, 117 (42), 26438 - 26447. doi:10.1073/pnas.2009838117en_US
dc.identifier.issn0027-8424-
dc.identifier.urihttp://arks.princeton.edu/ark:/88435/pr1td9n73q-
dc.description.abstractMetabolic dysfunction occurs in many age-related neurodegenerative diseases, yet its role in disease etiology remains poorly understood. We recently discovered a potential causal link between the branched-chain amino acid transferase <i>BCAT-1</i> and the neurodegenerative movement disorder Parkinson's disease (PD). RNAi-mediated knockdown of <i>Caenorhabditis elegans bcat-1</i> is known to recapitulate PD-like features, including progressive motor deficits and neurodegeneration with age, yet the underlying mechanisms have remained unknown. Using transcriptomic, metabolomic, and imaging approaches, we show here that <i>bcat-1</i> knockdown increases mitochondrial respiration and induces oxidative damage in neurons through mammalian target of rapamycin-independent mechanisms. Increased mitochondrial respiration, or "mitochondrial hyperactivity," is required for <i>bcat-1(RNAi)</i> neurotoxicity. Moreover, we show that post-disease-onset administration of the type 2 diabetes medication metformin reduces mitochondrial respiration to control levels and significantly improves both motor function and neuronal viability. Taken together, our findings suggest that mitochondrial hyperactivity may be an early event in the pathogenesis of PD, and that strategies aimed at reducing mitochondrial respiration may constitute a surprising new avenue for PD treatment.en_US
dc.format.extent26438 - 26447en_US
dc.languageengen_US
dc.language.isoen_USen_US
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of Americaen_US
dc.rightsFinal published version. This is an open access article.en_US
dc.titleMetformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondriaen_US
dc.typeJournal Articleen_US
dc.identifier.doidoi:10.1073/pnas.2009838117-
dc.identifier.eissn1091-6490-
pu.type.symplectichttp://www.symplectic.co.uk/publications/atom-terms/1.0/journal-articleen_US

Files in This Item:
File Description SizeFormat 
metformin_rescues_parkinsons_hyperactive_mitochondria.pdf5.7 MBAdobe PDFView/Download


Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.